Growth Metrics

Opus Genetics (IRD) Total Debt (2019 - 2026)

Opus Genetics (IRD) reported Total Debt of $1.2 million for Q1 2026, down 90.58% year-over-year from $12.7 million in Q1 2025, and up 6.11% on a QoQ basis from $1.1 million in Q4 2025.

Opus Genetics (IRD) has 5 years of Total Debt data on file, last reported at $1.2 million in Q1 2026.

  • Quarterly Total Debt fell 90.58% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 90.58% YoY) and the FY2025 annual result came in at $1.1 million, changed N/A from the prior year.
  • Total Debt rose to $1.2 million in Q1 2026 per IRD's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Total Debt topped out at $22.4 million in Q3 2025 and bottomed at $93000.0 in Q3 2023.
  • The 4-year median for Total Debt is $1.2 million (2026), against an average of $7.2 million.
  • Peak annual rise in Total Debt reached 90.58% in 2026, while the deepest fall reached 90.58% in 2026.
  • Tracing IRD's Total Debt over 4 years: stood at $215000.0 in 2022, then tumbled by 56.74% to $93000.0 in 2023, then soared by 1113.98% to $1.1 million in 2025, then rose by 6.11% to $1.2 million in 2026.
  • Per Business Quant, the three latest IRD Total Debt figures stand at $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $22.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 319.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.96 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.99 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Opus Genetics 357.99 Mn 298.03 Mn - 1.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 22.39 Mn
Jun 30, 2025 12.80 Mn
Mar 31, 2025 12.72 Mn
Sep 30, 2023 93,000.00
Mar 31, 2022 215,000.00
Dec 31, 2019 2.71 Mn